Skip to main content
OpenTrials
Completed

NCT Number: NCT05842577

RCT on Telerehabilitation Efficacy in Parkinson's Disease

The implementation of regular prolonged, and effective rehabilitation in people with Parkinson's disease is essential for ensuring a good quality of life. However, the continuity of rehabilitation care may find barriers related to economic, geographic, and social issues. In these scenarios, telerehabilitation could be a possible solution to guarantee the continuity of care.

This trial aims to investigate the efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in people with Parkinson's disease, compared to at-home conventional rehabilitation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Parkinson Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Synucleinopathies

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

IRCCS Bonino-Pulejo, Messina, Italy

Loading trial locations.

About this study

Parkinson's Disease (PD) is a chronic degenerative pathology characterized by both motor and non-motor symptoms that may have a significant long-term impact on Activities of Daily Living (ADL).

Subjects with PD need continuous, intensive, and tailored rehabilitation in order to improve motor function as well as their Quality of Life (QoL), and to reduce the risk of balance impairment and falls. Thus, the implementation of regular prolonged, and effective rehabilitation in people with PD is essential for ensuring well-being.

In this scenario, the delivery of rehabilitation services at distance, namely TeleRehabilitation (TR), is a possible solution to guarantee the continuity of care and physical exercise at home via digital healthcare.

Although the TR intervention has been proposed as a sustainable and innovative approach in people with PD, there are still conflicting results in the literature about its efficacy.

This study aims to investigate the efficacy of non-immersive VR-based TR on postural stability in people with PD, compared to at-home conventional rehabilitation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hoehn & Yahr (H&Y) score between ≤3 (ON-state);
  • the absence of moderate and severe dyskinesias assessed by the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) with a score of items 4.1 and 4.2 < 3;
  • the absence of moderate and severe freezing episodes assessed by the MDS-UPDRS with a score of items 2.13 and 3.11 < 3;
  • the ability to perform the 6 Minutes Walking Test (6MWT) between 200 m and 600 m;
  • age ≤ 80 years;
  • the absence of cognitive impairment measured by the Montreal Cognitive Assessment (MoCA) total score≥17.54 ;
  • stabilized drug treatment;
  • sufficient cognitive and linguistic level to understand and comply with study procedures;
  • sign informed consent.

Exclusion criteria

  • other neurological pathologies, psychiatric complications, or personality disorders;
  • blurred or low vision problems;
  • hearing and speech impairment affecting participation in the study.

Treatment and study plan

VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy)

Device

The motor exercises were performed using inertial sensors for the acquisition and processing of the movement performed by the patient. The patient was trained to perform these exercises using visual and auditory feedback in a serious game environment. The exercises were aimed at the rehabilitation of balance and at the improvement of motor performance in lower limbs (e.g., maintaining balance on one leg, marching in place, standing on tiptoe, squatting, etc.). The therapists involved in the study customized the protocol of exercises in TR mode according to the characteristics and needs of the subject.

At-home conventional rehabilitation

Other

The CG rehabilitation was an active comparator treatment and consisted of a written home-based self-administered booklet with conventional motor activities tailored for each subject. The motor activities were chosen and adapted from a specialized manual. The motor exercises were aimed at the rehabilitation of balance and at the improvement of motor performance in lower limbs (e.g., maintaining balance on one leg, marching in place, standing on tiptoe, squatting, etc).

Other names: Structured self-administered exercises

Primary outcomes

  1. Change in the mini-Balance Evaluation Systems Test (mini-BESTest)

    Time frame: Session 1 (Baseline, T0), Session 30 (End of treatment, approximately 10 weeks, T1)]

    The mini-BESTest is a shortened version of the Balance Evaluation Systems Test. It aims to target and identify 6 different balance control systems so that specific rehabilitation approaches can be designed for different balance deficits. The test was shortened based on factor analysis to include dynamic balance only and to improve clinical utilization. It is 36 items scale that evaluates Balance with total score of 28.

Secondary outcomes

  1. Change in the Timed Up and Go test (TUG)

    Time frame: Session 1 (Baseline, T0), Session 30 (End of treatment, approximately 10 weeks, T1)]

    The TUG test assesses mobility, balance, walking ability, and fall risk in older adults. It is a measure of function with correlates to balance and fall risk. The participant is asked to get up from the chair she/he is sitting in, walk the marked distance of 3 meters and return to her/his seat again. The elapsed time is recorded in seconds.

  2. Change in the 6-minute WalkTest (6mWT)

    Time frame: Session 1 (Baseline, T0), Session 30 (End of treatment, approximately 10 weeks, T1)]

    The 6mWT assesses the functional exercise capacity. The patient is asked to walk as long as possible for 6 minutes at a self-selected speed. The distance is recorded in meters.

  3. Change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) - part III

    Time frame: Session 1 (Baseline, T0), Session 30 (End of treatment, approximately 10 weeks, T1)]

    MDS-UPDRS is a multimodal scale assessing impairment and disability consisting of 4 parts. Part III assessed the motor signs of PD and was administered by the rater (Range 0-132). Part III contained 33 scores based on 18 items. For each question, a numeric score was assigned between 0-4, where 0 = Normal, 1 = Slight, 2 = Mild, 3 = Moderate, 4 = Severe. A higher score indicated more severe symptoms of PD.

Sponsors and collaborators

Lead sponsor

IRCCS San Raffaele Roma

Other

Collaborators

  • Fondazione Don Carlo Gnocchi ETS
  • Fondazione Salvatore Maugeri
  • IRCCS Centro Neurolesi Bonino Pulejo
  • IRCCS National Neurological Institute "C. Mondino" Foundation
  • IRCCS San Camillo, Venezia, Italy

Registry information

Official study title

Efficacy of Non-immersive Virtual Reality-based Telerehabilitation in Parkinson's Disease: a Multicentre Randomized Controlled Trial

Acronym: REPORT

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
May 6, 2023
Registry last updated
Jun 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.